IDH mutant gliomas additionally have distinct morphology and co-occurring molecular alterations; 1p/19q-codeletion and TERT promoter mutation in oligodendroglioma and p53/ATRX mutations in IDH mutant astrocytoma. This evidence concerns the gene IDH2 and central nervous system cancer.